ARCA:XPH

State Street SPDR S&P Pharmaceuticals ETF

$ 70.93 -0.1 ( -0.14%) 04:00 PM EST
PE Ratio:
13.48
PB Ratio:
3.01
Volume:
69.23K
Dividend Yield %:
0.49
Last Holding update 2026-08-28 65 Stocks (10 new)
Value $428.00 Mil Turnover 42 %
Top Holdings: DFTX(3.09%) MBX(2.72%) ALMS(2.14%) ATAI(2.13%) TRVI(2.12%)
Registrant: State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
Year: 2026
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

GuruFocus Rankings

Financial Strength
6 /10
Profitability Rank
4 /10
GF Value Rank
4 /10
Growth Rank
6 /10
Momentum Rank
5 /10

State Street SPDR S&P Pharmaceuticals ETF Geographic Breakdown

State Street SPDR S&P Pharmaceuticals ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

State Street SPDR S&P Pharmaceuticals ETF Key Statistics

Name Value
Day's Open ($) 70.52
Day's Range ($) 70.33 - 71.13
Day's Volume 69,228
52-Week Range ($) 45.8 - 74.345
Beta 0.6929
3-Year Sharpe Ratio 0.67
3-Year Sortino Ratio 1.17
Volatility 17.48
14-Day RSI 51.43
14-Day ATR ($) 1.245643
20-Day SMA ($) 71.4525

Fundamental Data

Name Value
Market Cap (Mil $) 574.552
Shares Outstanding (Mil) 8.1
PE Ratio 13.48
PE Ratio (10y Range) 6.7 - 55.82
PE Ratio (10y Median) 17.92
PB Ratio 3.01
PB Ratio (10y Range) 0.17 - 3.75
PB Ratio (10y Median) 2.46

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.345
Dividend Yield % 0.49
Dividend Yield % (10y Range) 0.45 - 1.79
Dividend Yield % (10y Median) 0.81
Next Dividend Payment Date
Dividend Frequency Quarterly

XPH State Street SPDR S&P Pharmaceuticals ETF Fundamental Charts

Historical TTM Price-to-Earnings for XPH State Street SPDR S&P Pharmaceuticals ETF

Historical TTM Price-to-Earnings without NRI for XPH State Street SPDR S&P Pharmaceuticals ETF

Historical Price-to-Book Ratio for XPH State Street SPDR S&P Pharmaceuticals ETF

Historical Dividend Yields for XPH State Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:XPH

No Available Data

ARCA:XPH is held by these investors

No Available Data
State Street(R) SPDR(R) S&P(R)... Top Holdings of 2026-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
DFTX
Definium Therapeutics Inc
281,317
13,233.1
-18.71%
3.090
-0.38%
0.210
+54.86%
+184.39%
5,116.7
Biotechnology
MBX
MBX Biosciences Inc
210,962
11,645.1
+41.91%
2.720
+0.80%
0.440
+99.45%
+95.47%
2,969.1
Biotechnology
ALMS
Alumis Inc
325,914
9,171.2
+331.94%
2.140
+1.64%
0.250
-45.61%
+13.63%
1,480.5
Biotechnology
ATAI
AtaiBeckley Inc
1,729,574
9,114.9
New Holding
2.130
+2.13%
0.470
+64.22%
+80.68%
2,740.7
Biotechnology
TRVI
Trevi Therapeutics Inc
487,893
9,099.2
+61.36%
2.120
+0.81%
0.340
+23.94%
+37.90%
2,459.8
Biotechnology
ELVN
Enliven Therapeutics Inc
176,696
8,967.3
+9.35%
2.090
+0.18%
0.240
+67.15%
+285.19%
4,346.4
Biotechnology
AMLX
Amylyx Pharmaceuticals Inc
485,721
8,723.5
+49.99%
2.040
+0.68%
0.440
+138.57%
+182.62%
3,804.0
Drug Manufacturers
MANE
Veradermics Inc
70,310
8,643.9
New Holding
2.020
+2.02%
0.170
-2.69%
-
4,115.8
Biotechnology
LGND
Ligand Pharmaceuticals Inc
26,334
8,323.9
+13.11%
1.940
+0.22%
0.130
+21.06%
+51.06%
5,693.6
Biotechnology
NUVB
Nuvation Bio Inc
1,427,463
8,108.0
+161.21%
1.890
+1.17%
0.410
+31.72%
-24.00%
2,391.1
Biotechnology

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Historical Top Holdings Breakdowns

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
ATAI
AtaiBeckley Inc
2026-06-30
New Buy
New Buy
+2.13%
●
3.54 ($4.2) 5.36
$7.39
75.95%
New holding
1,729,574
1,729,574
MANE
Veradermics Inc
2026-06-30
New Buy
New Buy
+2.02%
●
56.71 ($93.19) 126.89
$98.51
5.71%
New holding
70,310
70,310
TERN Unlock Delisted
Terns Pharmaceuticals Inc
2026-06-30
Sold Out
Sold Out
-1.69%
●
52.56 ($52.79) 52.95
$52.95
0.30%
Sold Out
0
-96,040
ALMS
Alumis Inc
2026-06-30
Add
Add
+1.64%
●
18.99 ($23.25) 28.14
$11.09
-52.30%
Add 331.94%
325,914
250,461
BIOA
Bioage Labs Inc
2026-06-30
New Buy
New Buy
+1.50%
●
15.34 ($18.06) 24.95
$9.59
-46.90%
New holding
262,153
262,153
ETON
Eton Pharmaceuticals Inc
2026-06-30
New Buy
New Buy
+1.31%
●
22.97 ($29.25) 36.73
$58.44
99.79%
New holding
154,434
154,434
WVE
Wave Life Sciences Inc
2026-06-30
Add
Add
+1.28%
●
5.66 ($6.64) 7.59
$4.85
-26.96%
Add 445.42%
1,155,091
943,309
MAZE
Maze Therapeutics Inc
2026-06-30
Add
Add
+1.18%
●
23.58 ($26.27) 29.85
$26.21
-0.23%
Add 176.63%
265,830
169,733
ANRO
Alto Neuroscience Inc
2026-06-30
New Buy
New Buy
+1.17%
●
18.24 ($23.11) 28.07
$35.55
53.83%
New holding
190,203
190,203
NUVB
Nuvation Bio Inc
2026-06-30
Add
Add
+1.17%
●
4.21 ($4.88) 6.46
$6.81
39.55%
Add 161.21%
1,427,463
880,990

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF Total Holding History ($B)

To

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Asset Allocation

To

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Hypothetical Growth since 2026-06-30

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Yearly Returns

This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.

Year Portfolio % % Excess Gain %

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Holdings Heat Map

Size field:

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF's Holdings Bubble Chart

Discussions on State Street SPDR S&P Pharmaceuticals ETF

User's Avatar
How would you rate this stock? XPH
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文
Education
Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2026 GuruFocus.com, LLC. All Rights Reserved.